摘要
目的:研究在预防产后出血中联合使用麦角新碱、缩宫素和卡前列甲酯栓3种药物的临床效果。方法:选取60例产妇作为观察对象,均于2017年8月～2018年6月在我院分娩。先给予卡前列甲酯栓和缩宫素进行干预,结果发现预防效果欠佳,在此基础上添加麦角新碱进行干预,观察治疗效果。结果:产后出血发生率为11.67%,2h和24h的平均出血量分别为(287.17±45.33)m L、(310.45±56.18)mL。结论:麦角新碱联合缩宫素与卡前列甲酯栓预防产后出血的临床效果显著,值得推广。
Objective:to study the clinical effect of the combined use of ergocerine,oxytocin and calfront methyl ester suppository in the prevention of postpartum hemorrhage.Methods:60 parturients were selected as the observation subjects.All of them were delivered in our hospital from August 2017 to June 2018.The results showed that the preventive effect was not good enough.On this basis,ergocerine was added for intervention,and the therapeutic effect of 60 parturients was observed.Results:the incidence of postpartum hemorrhage in60 patients was 11.67%,and the average blood loss at 2 h and 24 h was(287.17±45.33)m L,(310.45±56.18)m L,respectively.Conclusion:ergodicine combined with oxytocin and proformin suppository is effective in preventing postpartum hemorrhage.
作者
刘雪花
杨林
Liu Xuehua;Yanglin(Dongguan eighth people's hospital obstetrics and gynecology dongguan,guangdong 523000)
出处
《北方药学》
2019年第4期11-12,共2页
Journal of North Pharmacy
